近期论文

查看导师最新文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. McNamara, K.M.; Moore, N.L.; Hickey, T.E.; Sasano, H.; Tilley, W.D. Complexities of androgen receptor signalling in breast cancer. Endocrine-Related Cancer, 2014; 21(4):T161-T181 2. Moore, N.L.; Edwards, D.P.; Weigel, N.L. Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology, 2014; 144:471-482 3. Ochnik, A.M.; Moore, N.L.; Jankovic-Karasoulos, T.; Bianco-Miotto, T.; Ryan, N.K.; Thomas, M.R.; Birrell, S.N.; Butler, L.M.; Tilley, W.D.; Hickey, T.E. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo. Menopause, 2014; 21(1):79-88 4. Moore, N.; Buchanan, G.; Harris, J.; Selth, L.; Bianco-Miotto, T.; Hanson, A.; Birrell, S.; Butler, L.; Hickey, T.; Tilley, W. An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity. Endocrine-Related Cancer, 2012; 19(4):599-613 5. Moore, N.; Hickey, T.; Butler, L.; Tilley, W. Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells. Molecular and Cellular Endocrinology, 2012; 357(1-2):60-70 6. Moore, N.L.; Weigel, N.L. Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminus. The International Journal of Biochemistry & Cell Biology, 2011; 43(8):1157-1167 7. Need, E.; Scher, H.; Peters, A.; Moore, N.; Cheong, A.; Ryan, C.; Wittert, G.; Marshall, V.; Tilley, W.; Buchanan, G. A Novel Androgen Receptor Amino Terminal Region Reveals Two Classes of Amino/Carboxyl Interaction-Deficient Variants with Divergent Capacity to Activate Responsive Sites in Chromatin. Endocrinology, 2009; 150(6):2674-2682 8. Peters, A.; Buchanan, G.; Ricciardelli, C.; Bianco-Miotto, T.; Centenera, M.; Harris, J.; Jindal, S.; Segara, D.; Jia, L.; Moore, N.; Henshall, S.; Birrell, S.; Coetzee, G.; Sutherland, R.; Butler, L.; Tilley, W. Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer Research, 2009; 69(15):6131-6140 9. Cops, E.; Bianco-Miotto, T.; Moore, N.; Clarke, C.; Birrell, S.; Butler, L.; Tilley, W. Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors. Journal of Steroid Biochemistry and Molecular Biology, 2008; 110(3-5):236-243 10. Moore, N.; Narayanan, R.; Weigel, N. Cyclin dependent kinase 2 and the regulation of human progesterone receptor activity. Steroids, 2007; 72(2):202-209 11. Weigel, N.; Moore, N. Cyclins, cyclin dependent kinases, and regulation of steroid receptor action. Molecular and Cellular Endocrinology, 2007; 265?266:157-161 12. Weigel, N.; Moore, N. Kinases and protein phosphorylation as regulators of steroid hormone action. Nuclear Receptor Signaling, 2007; 5:1-13 13. Weigel, N.; Moore, N. Steroid receptor phosphorylation: a key modulator of multiple receptor functions. Molecular Endocrinology, 2007; 21(10):2311-2319 14. Srinivas, H.; Xia, D.; Moore, N.; Uray, I.; Kim, H.; Ma, L.; Weigel, N.; Brown, P.; Kurie, J. Akt phosphorylates and suppresses the transactivationof retinoic acid receptor alpha. Biochemical Journal, 2006; 395(3):653-662 15. Buchanan, G.; Birrell, S.; Peters, A.; Bianco-Miotto, T.; Ramsay, K.; Cops, E.; Yang, M.; Harris, J.; Simila, H.; Moore, N.; Bentel, J.; Ricciardelli, C.; Horsfall, D.; Butler, L.; Tilley, W. Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. Cancer Research, 2005; 65(18):8487-8496 16. Buchanan, G.; Yang, M.; Cheong, A.; Harris, J.; Irvine, R.; Lambert, P.; Moore, N.; Raynor, M.; Neufing, P.; Coetzee, G.; Tilley, W. Structural and functional consequences of glutamine tract variation in the androgen receptor. Human Molecular Genetics, 2004; 13(16):1677-1692 17. Buchanan, G.; Yang, M.; Harris, J.; Nahm, H.; Han, G.; Moore, N.; Bentel, J.; Matusik, R.; Horsfall, D.; Marshall, V.; Greenberg, N.; Tilley, W. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Molecular Endocrinology, 2001; 15(1):45-56